➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Express Scripts
Baxter
Johnson and Johnson
Boehringer Ingelheim

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Dolastatin 10

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Dolastatin 10?

Dolastatin 10 is an investigational drug.

There have been 7 clinical trials for Dolastatin 10. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 1999.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, and Carcinoma, Renal Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Barbara Ann Karmanos Cancer Institute.

Recent Clinical Trials for Dolastatin 10
TitleSponsorPhase
Dolastatin 10 in Treating Patients With Advanced Kidney CancerNational Cancer Institute (NCI)Phase 2
Dolastatin 10 in Treating Patients With Advanced Kidney CancerMayo ClinicPhase 2
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 2

See all Dolastatin 10 clinical trials

Clinical Trial Summary for Dolastatin 10

Top disease conditions for Dolastatin 10
Top clinical trial sponsors for Dolastatin 10

See all Dolastatin 10 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Express Scripts
Baxter
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.